Suppr超能文献

挪威接种疫苗后19A型肺炎球菌疾病的增加是由ST199复合体中对青霉素敏感菌株的扩增所驱动的。

Postvaccination increase in serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex.

作者信息

Vestrheim Didrik F, Steinbakk Martin, Aaberge Ingeborg S, Caugant Dominique A

机构信息

Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway.

出版信息

Clin Vaccine Immunol. 2012 Mar;19(3):443-5. doi: 10.1128/CVI.05563-11. Epub 2012 Jan 11.

Abstract

Serotype replacement in invasive pneumococcal disease has been observed after widespread use of the 7-valent pneumococcal conjugate vaccine (PCV7). Replacement is dominated by penicillin-nonsusceptible serotype 19A in several countries. Antibiotic selection pressure has been proposed to interact with immunization, leading to rapid replacement. In Norway, where prescription of antibiotics is limited, post-PCV7 replacement by serotype 19A is dominated by penicillin-susceptible clones. Hence, serotype 19A replacement occurs, although it is not driven by antibiotic selection pressure.

摘要

在广泛使用7价肺炎球菌结合疫苗(PCV7)后,侵袭性肺炎球菌疾病中出现了血清型替换现象。在一些国家,替换主要由对青霉素不敏感的19A血清型主导。有人提出抗生素选择压力与免疫接种相互作用,导致快速替换。在挪威,抗生素处方受到限制,PCV7接种后19A血清型的替换主要由对青霉素敏感的克隆主导。因此,尽管血清型19A的替换并非由抗生素选择压力驱动,但这种替换仍会发生。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验